Organ Transplantation Research Today is a free monthly online journal that collates and summarizes the latest research about Organ Transplantation, including details on risks, prognosis, procedure, surgery.

Volume 2 (2005), Issue 1 (January)

1. Renal transplantation, immunosuppression and the skin: an update.
   Photodermatol Photoimmunol Photomed, 21(1): 1-8. [Abstract] [Full-text]
2. Tissue response to poly-L-lactide acid-polyglycolic acid absorbable screws in autogenous bone grafts: a histologic morphological analysis.
   Clin Oral Implants Res, 16(1): 112-8. [Abstract] [Full-text]
3. Disseminated intravascular coagulation (DIC) in a kidney donor associated with transient recipient DIC.
   Am J Transplant, 5(2): 412-4. [Abstract] [Full-text]
4. MMF and calcineurin taper in recurrent hepatitis C after liver transplantation: impact on histological course.
   Am J Transplant, 5(2): 406-11. [Abstract] [Full-text]
5. Living donor and split-liver transplants in hepatitis C recipients: does liver regeneration increase the risk for recurrence?
   Am J Transplant, 5(2): 399-405. [Abstract] [Full-text]
6. Association between pulse pressure and cardiovascular disease in renal transplant patients.
   Am J Transplant, 5(2): 394-8. [Abstract] [Full-text]
7. Antibody response against the glomerular basement membrane protein agrin in patients with transplant glomerulopathy.
   Am J Transplant, 5(2): 383-93. [Abstract] [Full-text]
8. Impact of simultaneous kidney-pancreas transplant and timing of transplant on kidney allograft survival.
   Am J Transplant, 5(2): 374-82. [Abstract] [Full-text]
9. BKV in simultaneous pancreas-kidney transplant recipients: a leading cause of renal graft loss in first 2 years post-transplant.
   Am J Transplant, 5(2): 366-73. [Abstract] [Full-text]
10. African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression.
    Am J Transplant, 5(2): 356-65. [Abstract] [Full-text]
11. Rapid resolution of proteinuria of native kidney origin following live donor renal transplantation.
    Am J Transplant, 5(2): 351-5. [Abstract] [Full-text]
12. In vivo imaging of human pancreatic microcirculation and pancreatic tissue injury in clinical pancreas transplantation.
    Am J Transplant, 5(2): 341-50. [Abstract] [Full-text]
13. Operationally tolerant and minimally immunosuppressed kidney recipients display strongly altered blood T-cell clonal regulation.
    Am J Transplant, 5(2): 330-40. [Abstract] [Full-text]
14. Early presence of calcium oxalate deposition in kidney graft biopsies is associated with poor long-term graft survival.
    Am J Transplant, 5(2): 323-9. [Abstract] [Full-text]
15. Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression.
    Am J Transplant, 5(2): 314-22. [Abstract] [Full-text]
16. The survival benefit of liver transplantation.
    Am J Transplant, 5(2): 307-13. [Abstract] [Full-text]
17. Repair of damaged organs in vitro.
    Am J Transplant, 5(2): 300-6. [Abstract] [Full-text]
18. Caspase inhibition improves ischemia-reperfusion injury after lung transplantation.
    Am J Transplant, 5(2): 292-9. [Abstract] [Full-text]
19. Protection against ischemia/reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both.
    Am J Transplant, 5(2): 282-91. [Abstract] [Full-text]
20. Allo-specific T-cells encoding for viral IL-10 exert strong immunomodulatory effects in vitro but fail to prevent graft rejection.
    Am J Transplant, 5(2): 268-81. [Abstract] [Full-text]
21. Prolongation of heart allograft survival by immature dendritic cells generated from recipient type bone marrow progenitors.
    Am J Transplant, 5(2): 255-67. [Abstract] [Full-text]
22. A novel model for post-transplant obliterative airway disease reveals angiogenesis from the pulmonary circulation.
    Am J Transplant, 5(2): 248-54. [Abstract] [Full-text]
23. Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report.
    Am J Transplant, 5(2): 218-27. [Abstract] [Full-text]
24. Paradoxical cyclosporine A requirements in pediatric renal transplants receiving high-dose steroids.
    J Clin Pharmacol, 45(2): 161-7. [Abstract] [Full-text]
25. HBV reactivation after kidney transplantation.
    J Clin Virol, 32(2): 162-5. [Abstract] [Full-text]
26. Treatment with {alpha}-phenyl-N-tert-butylnitrone, a free radical-trapping agent, abrogates inflammatory cytokine gene expression during alloimmune activation in rat cardiac allografts.
    J Pharmacol Exp Ther, 312(2): 774-9. [Abstract] [Full-text]
27. Treatment of unprotected left main coronary artery stenosis with a drug eluting stent in a heart transplant patient with allograft vasculopathy.
    Heart, 91(2): e11. [Abstract] [Full-text]
28. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab.
    Clin Transplant, 19(1): 137-40. [Abstract] [Full-text]
29. Economic evaluation of everolimus vs. azathioprine at one year after de novo heart transplantation.
    Clin Transplant, 19(1): 122-9. [Abstract] [Full-text]
30. Acitretin and skin cancer in kidney transplanted patients. Clinical and histological evaluation and immunohistochemical analysis of lymphocytes, natural killer cells and Langerhans' cells in sun exposed and sun protected skin.
    Clin Transplant, 19(1): 115-21. [Abstract] [Full-text]
31. Lobular damage caused by cellular and humoral immunity in liver allograft rejection.
    Clin Transplant, 19(1): 110-4. [Abstract] [Full-text]
32. Prevalence, characteristics, and outcome of BK virus nephropathy in Japanese renal transplant patients: analysis in protocol and episode biopsies.
    Clin Transplant, 19(1): 97-101. [Abstract] [Full-text]
33. Living donors' experiences 1 wk after donating a kidney.
    Clin Transplant, 19(1): 90-6. [Abstract] [Full-text]
34. Induction therapy with either anti-CD25 monoclonal antibodies or rabbit antithymocyte globulins in liver transplantation for hepatitis C.
    Clin Transplant, 19(1): 83-9. [Abstract] [Full-text]
35. Comparing renal transplant patients' adherence to free cyclosporine and free tacrolimus immunosuppressant therapy.
    Clin Transplant, 19(1): 77-82. [Abstract] [Full-text]
36. Factors modifying stress from adverse effects of immunosuppressive medication in kidney transplant recipients.
    Clin Transplant, 19(1): 70-6. [Abstract] [Full-text]
37. Steroid avoidance in renal transplantation using basiliximab induction, cyclosporine-based immunosuppression and protocol biopsies.
    Clin Transplant, 19(1): 61-9. [Abstract] [Full-text]
38. Standard chronic immunosuppression after kidney transplantation for systemic lupus erythematosus eliminates recurrence of disease.
    Clin Transplant, 19(1): 56-60. [Abstract] [Full-text]
39. Novel rescue therapy for C4d-positive acute humoral renal allograft rejection.
    Clin Transplant, 19(1): 51-5. [Abstract] [Full-text]
40. Incidence of serum creatine kinase elevation and its relation to medications used after heart transplantation.
    Clin Transplant, 19(1): 45-50. [Abstract] [Full-text]
41. Psychosocial profiling: a holistic management tool for non-compliance.
    Clin Transplant, 19(1): 38-44. [Abstract] [Full-text]
42. Organ donation: a population-based study.
    Clin Transplant, 19(1): 33-7. [Abstract] [Full-text]
43. A prospective 3-yr evaluation of tacrolimus-based immunosuppressive therapy in immunological high risk renal allograft recipients.
    Clin Transplant, 19(1): 26-32. [Abstract] [Full-text]
44. The need of mycophenolic acid monitoring in long-term renal transplants.
    Clin Transplant, 19(1): 19-25. [Abstract] [Full-text]
45. A survey of dental care protocols among US organ transplant centers.
    Clin Transplant, 19(1): 15-8. [Abstract] [Full-text]
46. Angiotensinogen and plasminogen activator inhibitor-1 gene polymorphism in relation to chronic allograft dysfunction.
    Clin Transplant, 19(1): 10-4. [Abstract] [Full-text]
47. Objective measures of health-related quality of life over 24 months post-liver transplantation.
    Clin Transplant, 19(1): 1-9. [Abstract] [Full-text]
48. EAU guidelines on renal transplantation.
    Eur Urol, 47(2): 156-66. [Abstract] [Full-text]
49. Chronic myeloid leukemia following kidney transplantation.
    Leuk Res, 29(3): 353-5. [Abstract] [Full-text]
50. Indication of liver transplantation following amatoxin intoxication.
    J Hepatol, 42(2): 202-9. [Abstract] [Full-text]
51. Development of hepatopulmonary syndrome and portopulmonary hypertension in a paediatric liver transplant patient.
    Pediatr Transplant, 9(1): 127-31. [Abstract] [Full-text]
52. Reversal of tacrolimus-related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6-year-old recipient.
    Pediatr Transplant, 9(1): 117-21. [Abstract] [Full-text]
53. Fulminant hepatic failure: Wilson's disease or autoimmune hepatitis? Implications for transplantation.
    Pediatr Transplant, 9(1): 112-6. [Abstract] [Full-text]
54. Improved outcome of pediatric kidney transplantations in the Netherlands -- effect of the introduction of mycophenolate mofetil?
    Pediatr Transplant, 9(1): 104-11. [Abstract] [Full-text]
55. Gastrointestinal leukocytoclastic vasculitis: an adverse effect of sirolimus.
    Pediatr Transplant, 9(1): 97-100. [Abstract] [Full-text]
56. Severe neutropenia and thrombocytopenia following cardiac transplantation in a child.
    Pediatr Transplant, 9(1): 94-6. [Abstract] [Full-text]
57. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation.
    Pediatr Transplant, 9(1): 84-93. [Abstract] [Full-text]
58. Mycophenolate mofetil in pediatric renal transplantation: non-induction vs. induction with basiliximab.
    Pediatr Transplant, 9(1): 80-3. [Abstract] [Full-text]
59. Ascites after orthotopic liver transplantation in children.
    Pediatr Transplant, 9(1): 74-9. [Abstract] [Full-text]
60. Pediatric renal transplantation: single center experience.
    Pediatr Transplant, 9(1): 56-61. [Abstract] [Full-text]
61. Liver transplantation utilizing pediatric cadaver donor livers.
    Pediatr Transplant, 9(1): 47-51. [Abstract] [Full-text]
62. Sodium ferric gluconate for post-transplant anemia in pediatric and young adult renal transplant recipients.
    Pediatr Transplant, 9(1): 43-6. [Abstract] [Full-text]
63. Excellent outcome in infants and small children with thrombophilias undergoing kidney transplantation.
    Pediatr Transplant, 9(1): 39-42. [Abstract] [Full-text]
64. Surgical complications in live-donor pediatric and adolescent renal transplantation: study of risk factors.
    Pediatr Transplant, 9(1): 33-8. [Abstract] [Full-text]
65. Intra-individual variation of cystatin C and creatinine in pediatric solid organ transplant recipients.
    Pediatr Transplant, 9(1): 28-32. [Abstract] [Full-text]
66. Psychosocial impact of living-related kidney transplantation on donors and partners.
    Pediatr Nephrol, 20(2): 205-9. [Abstract] [Full-text]
67. Incidence and predictors of myocardial infarction after kidney transplantation.
    J Am Soc Nephrol, 16(2): 496-506. [Abstract] [Full-text]
68. Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience.
    Pediatr Nephrol, 20(2): 210-6. [Abstract] [Full-text]
69. Relation of QTc duration heterogeneity to mortality following orthotopic heart transplantation.
    Am J Cardiol, 95(3): 431-2. [Abstract] [Full-text]
70. Statin use and risks of death or fatal rejection in the Heart Transplant Lipid Registry.
    Am J Cardiol, 95(3): 367-72. [Abstract] [Full-text]
71. Methemoglobinemia secondary to topical benzocaine use in a lung transplant patient.
    Ann Pharmacother, 39(2): 373-6. [Abstract] [Full-text]
72. Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism.
    Osteoporos Int, 16(2): 142-8. [Abstract] [Full-text]
73. Effect of synthetic protease inhibitor gabexate mesilate on the attenuation of ischemia/reperfusion injury in canine kidney autotransplantation.
    Surgery, 137(2): 216-24. [Abstract] [Full-text]
74. Metabolic demand and renal mass supply affecting the early graft function after living donor kidney transplantation.
    Kidney Int, 67(2): 744-9. [Abstract] [Full-text]
75. Acute effect of CyA A (Neoral) on large artery hemodynamics in renal transplant patients.
    Kidney Int, 67(2): 732-7. [Abstract] [Full-text]
76. Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation.
    Kidney Int, 67(2): 714-20. [Abstract] [Full-text]
77. Iron overload in kidney transplants: prospective analysis of biochemical and genetic markers.
    Kidney Int, 67(2): 691-7. [Abstract] [Full-text]
78. Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center.
    Liver Transpl, 11(2): 152-60. [Abstract] [Full-text]
79. The hepatic regeneration power of mild steatotic grafts is not impaired in living-donor liver transplantation.
    Liver Transpl, 11(2): 210-7. [Abstract] [Full-text]
80. Presence of multiple bile ducts in the liver graft increases the incidence of biliary complications in pediatric liver transplantation.
    Liver Transpl, 11(2): 161-6. [Abstract] [Full-text]
81. MELD fails to measure quality of life in liver transplant candidates.
    Liver Transpl, 11(2): 218-23. [Abstract] [Full-text]
82. Negative impact of systemic catecholamine administration on hepatic blood perfusion after porcine liver transplantation.
    Liver Transpl, 11(2): 174-87. [Abstract] [Full-text]
83. How common is delayed cyclosporine absorption following liver transplantation?
    Liver Transpl, 11(2): 167-73. [Abstract] [Full-text]
84. Preharvest donor hyperoxia predicts good early graft function and longer graft survival after liver transplantation.
    Liver Transpl, 11(2): 140-51. [Abstract] [Full-text]
85. Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy.
    Liver Transpl, 11(2): 196-202. [Abstract] [Full-text]
86. Noninvasive ventilation for pediatric patients including those under 1-year-old undergoing liver transplantation.
    Liver Transpl, 11(2): 188-95. [Abstract] [Full-text]
87. Liver transplantation for HELLP syndrome.
    Liver Transpl, 11(2): 224-8. [Abstract] [Full-text]
88. Colonization with methicillin-resistant Staphylococcus aureus after liver transplantation.
    Liver Transpl, 11(2): 203-9. [Abstract] [Full-text]
89. Liver transplantation with simultaneous removal of an intracardiac transjugular intrahepatic portosystemic shunt and a vena cava filter without the utilization of cardiopulmonary bypass.
    Liver Transpl, 11(2): 229-32. [Abstract] [Full-text]
90. Amelioration of hypertrophic cardiomyopathy using nonsurgical septal ablation in a cirrhotic patient prior to liver transplantation.
    Liver Transpl, 11(2): 236-8. [Abstract] [Full-text]
91. Effects of progesterone and selective oestrogen receptor modulators on chronic allograft nephropathy in rats.
    Nephrol Dial Transplant, 20(2): 329-35. [Abstract] [Full-text]
92. Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients.
    Nephrol Dial Transplant, 20(2): 413-8. [Abstract] [Full-text]
93. Impact of graft failure on patient survival on dialysis: a comparison of transplant-naive and post-graft failure mortality rates.
    Nephrol Dial Transplant, 20(2): 387-91. [Abstract] [Full-text]
94. Intratracheal administration of liposomal clodronate accelerates alveolar macrophage reconstitution following fetal liver transplantation.
    J Leukoc Biol, 77(2): 173-80. [Abstract] [Full-text]
95. Effects of postmortem heparinization in canine lung transplantation with non-heart-beating donors.
    J Thorac Cardiovasc Surg, 129(2): 429-34. [Abstract] [Full-text]
96. A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings.
    J Thorac Cardiovasc Surg, 129(2): 423-8. [Abstract] [Full-text]
97. Rescue cardiac transplantation for early failure of the Fontan-type circulation in children.
    J Thorac Cardiovasc Surg, 129(2): 416-22. [Abstract] [Full-text]
98. Combined endothelial and myocardial protection by endothelin antagonism enhances transplant allograft preservation.
    J Thorac Cardiovasc Surg, 129(2): 407-15. [Abstract] [Full-text]
99. Adenovirus immunoregulatory E3 proteins prolong transplants of human cells in immunocompetent mice.
    Virus Res, 108(1): 149-59. [Abstract] [Full-text]
100. Immediate and long-term survival after surgery for lung cancer in heart transplant recipients.
     Ann Thorac Surg, 79(2): 438-42. [Abstract] [Full-text]
101. Long-term pulmonary function after living-donor lobar lung transplantation in adults.
     Ann Thorac Surg, 79(2): 418-25. [Abstract] [Full-text]
102. Sternal approximation for bilateral anterolateral transsternal thoracotomy for lung transplantation.
     Ann Thorac Surg, 79(2): e19-20. [Abstract] [Full-text]
103. Stone-bearing live-donor kidneys for transplantation.
     BJU Int, 95(3): 394-7. [Abstract] [Full-text]
104. Surgery for localized prostate cancer after renal transplantation.
     BJU Int, 95(3): 319-22. [Abstract] [Full-text]
105. Are the patients with post-transplant psychiatric consultation different from other medical-surgical consultation inpatients?
     Psychiatry Clin Neurosci, 59(1): 19-24. [Abstract] [Full-text]

© 2004-2008 Organ Transplantation Research Today. All Rights Reserved.